Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Flu Jab Offers Little Protection this Year. Researchers: No Reason to Panic 23/03/2022 Maayan Hoffman The flu shots that are being administered in the United States, as well as elsewhere in the northern hemisphere, are not reducing the risk of catching the dominant strain of the influenza virus (H3N2) that is circulating this year, the Centers for Disease Control and Prevention (CDC) in a March edition of its Morbidity and […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
J&J Teams up with African Centre to Find New Drugs to Address Antimicrobial Resistance 25/04/2022 Kerry Cullinan CAPE TOWN – A new partnership between African scientists and pharmaceutical company Johnson & Johnson (J&J), aimed at finding solutions to antimicrobial resistance (AMR), was launched in South Africa on Monday. The J&J Satellite Center for Global Health Discovery, housed at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Center, will […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Flu Jab Offers Little Protection this Year. Researchers: No Reason to Panic 23/03/2022 Maayan Hoffman The flu shots that are being administered in the United States, as well as elsewhere in the northern hemisphere, are not reducing the risk of catching the dominant strain of the influenza virus (H3N2) that is circulating this year, the Centers for Disease Control and Prevention (CDC) in a March edition of its Morbidity and […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Flu Jab Offers Little Protection this Year. Researchers: No Reason to Panic 23/03/2022 Maayan Hoffman The flu shots that are being administered in the United States, as well as elsewhere in the northern hemisphere, are not reducing the risk of catching the dominant strain of the influenza virus (H3N2) that is circulating this year, the Centers for Disease Control and Prevention (CDC) in a March edition of its Morbidity and […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Flu Jab Offers Little Protection this Year. Researchers: No Reason to Panic 23/03/2022 Maayan Hoffman The flu shots that are being administered in the United States, as well as elsewhere in the northern hemisphere, are not reducing the risk of catching the dominant strain of the influenza virus (H3N2) that is circulating this year, the Centers for Disease Control and Prevention (CDC) in a March edition of its Morbidity and […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
European Union Adopts a Common Standard for Electronic Information about all Medicines in the Region 22/02/2022 Kerry Cullinan Residents in the European Union will soon have access to a single electronic database with information about all medicine available in the region, following the European Medicines Regulatory Network’s adoption of a common standard for electronic product information (ePI). “This will enable any EU resident to get up-to-date information on all medicines available to patients […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> Posts navigation Older posts